In conjunction with this, it is notable that there are several neurodegenerative diseases for which research into ASO therapy is already being performed, including the form of ALS caused by mutations in the SOD1 gene [81, 88] (NCT01041222). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.